30-year Industry Veteran Brings Exceptional Track Record of Driving Growth and Value at Global Biopharmaceutical Companies Readers are referred to the cautionary note regarding Forward-looking Information at the end of this release Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, Aug.

Readers are referred to the cautionary notes regarding Forward-looking Information at the end of this release Listed TSX, Symbol:  CNJ WINNIPEG, June 3, 2011 /PRNewswire/ - Cangene Corporation (TSX: CNJ) today announces that the Biomedical Advanced Research and Development Authority ("BARDA"), the agency within the U.S.

Readers are referred to the cautionary notes regarding Forward-looking Information at the end of this release Listed TSX, Symbol: CNJ BALTIMORE AND WINNIPEG, May 2 /PRNewswire/ - Cangene Corporation's Baltimore-based injectable pharmaceutical contract-manufacturing subsidiary, Cangene bioPharma, Inc., has completed a US$11-million renovation of its sterile filling and support facility.

Readers are referred to the cautionary notes regarding Forward-looking information at the end of this release Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, April 20 /PRNewswire-FirstCall/ - Cangene Corporation today reports that it has signed a new agreement with Baxter Healthcare Corporation under which Cangene assumes the commercialization rights to WinRho(R) SDF (Rho(D) Immune Globulin Intravenous (Human)) for the U.S.

HOLMDEL, N.J., July 13 /PRNewswire/ -- Sparta Systems, Inc., a leading provider of enterprise quality and compliance management software,today announced that Cangene Corporation, a biopharmaceutical company that manufactures therapeutic antibody products, has deployed Sparta's TrackWise((R)) Enterprise Quality Management software to deliver its learning and training initiatives across its manufacturing operations in Canada and the United States.